Cotiviti Blog

2027 Star Ratings: How to prepare for what's next

Written by Marge Ciancetta | Nov 18, 2026, 7:17:56 PM

The 2027 Medicare Advantage (MA) Star Ratings point to an increasingly competitive environment defined by rising performance thresholds, narrower margins between star levels, and a growing emphasis on clinical outcomes. For MA plans, the takeaway is clear: long-term success will depend on understanding where the program is headed and adapting accordingly.

What the 2027 results tell us

At a high level, the 2027 Star Ratings show continued pressure across the industry. Only 37% of contracts achieved four stars or higher, yet 71% of beneficiaries remain enrolled in those highly rated contracts (Figure 1). This highlights the continued advantage enjoyed by top-performing plans, which can leverage quality bonus payments and stronger benefit offerings to attract and retain members.

Figure 1. Share of enrollment in rated contracts by overall Star Ratings from 2025–2027.

Beneath the surface, movement remains significant: 20% of contracts improved by at least half a star, while 42% declined by the same amount. Some plans gained as much as 1.5 stars while others lost as many as 2.5. These shifts reinforce just how sensitive Star Ratings have become to relatively small changes in performance.

The results also reflect ongoing pressure from rising cut points (Figure 2). Approximately 45% of cut points increased this year while only 22% declined. Although the pace of increase has slowed from previous years, plans still need to improve simply to maintain their current position.

 

Figure 2. Cut point comparison across measure categories from 2026–2027 Star Ratings.

Just as important, the gap between star levels continues to narrow. In 2023, the average spread between two- and five-star performance thresholds was roughly 18 percentage points. By 2027, that spread had fallen to approximately 11 points. This compression means small performance gains can create meaningful rating improvements, but small declines can have an equally significant negative impact.

Another factor plans should keep in mind is the ongoing impact of CMS guardrails (Figure 3). While guardrails limit how much cut points can change from year to year, they may also mask the full extent of future performance expectations. In some measures, underlying industry performance is improving more quickly than published cut points suggest, meaning plans that focus only on current thresholds may underestimate the level of improvement needed to remain competitive in the years ahead.

Figure 3. Guardrail increases from 2023–2027 Star Ratings.

Where the Star Ratings program is headed

The 2027 results are only one part of the story. CMS continues to reshape the program in ways that will fundamentally change how plans earn and maintain strong ratings.

One of the most significant changes is the ongoing shift toward clinical outcomes and quality measures. By the 2029 Star Ratings, operations measures are expected to account for none of the program's total weight, down from 17% today. At the same time, clinical measures are projected to represent roughly 80% of overall performance, up from 62%.

As a result, HEDIS® and pharmacy measures will become increasingly important. Together, they are expected to account for approximately half of the entire Star Ratings program. Measures related to medication adherence, preventive care, chronic disease management, and care gap closure will play a larger role in determining overall performance.

The removal of operations measures may also make earning high ratings more difficult. An analysis of the projected 2029 measure set found that the percentage of contracts achieving four stars or higher would decline from 37% to 27% if those future measures were applied today. The reason is straightforward: many of the measures being retired are measures on which plans currently perform well.

At the same time, CMS continues its transition toward digital quality measurement. As traditional chart review and medical record abstraction become less central to the program, plans will need stronger data-sharing capabilities, more reliable clinical documentation, and greater interoperability across provider networks.

Finally, ongoing legal and regulatory challenges could affect the program's future direction. Several active lawsuits raise questions regarding not only specific methodologies but also the inclusion of certain measures and data sources within the Star Ratings program. Because the measures implicated in these cases represent a substantial portion of the program, future rulings could have implications for the overall measure set and materially reshape how performance is evaluated. While the outcomes remain uncertain, plans should continue monitoring developments that could influence measure inclusion, weighting, and scoring methodologies.

Four priorities for sustained success

As the Star Ratings program evolves, plans should focus on four key areas to maintain and improve performance.

  • Keep pace with increasing rates: Develop forward-looking targets that anticipate future cut point increases.
  • Prioritize measures with compressing spread: Identify measures where relatively small performance gains could lead to meaningful rating increases and prioritize interventions accordingly.
  • Prepare for the Star Ratings program refocus: Shift resources and strategy toward the measures that will carry the most weight in the years ahead.
  • Proactively protect member sentiment: Continuously monitor feedback, identify recurring themes, and address friction points before they affect member satisfaction and survey results.

On-demand webinar: Decoding the 2027 Star Ratings

Watch our on-demand webinar as we unpack the 2027 Medicare Advantage Star Ratings and discuss what the findings mean for plans moving forward. Topics include:

  • Key takeaways from the results and industry performance trends
  • How rising cut points, narrowing measure spreads, and evolving CMS priorities are changing the path to four stars and higher
  • Strategies plans can use today to prepare for a future increasingly focused on clinical outcomes, medication adherence, and member experience